GENERIC Omeprazole

BRAND NAME Acifre, Famazole, Gastriloc, Lopep, Losec, Mepracid, Omenole, Omepron, OMZ 20, Opehex, Risek, Wilom, Puroxel, Zyom

DOSAGE USED FOR PATIENT 20mg IV od 20mg/cap BID

INDICATION Short- term treatment of active duodenal ulcer, gastro esophageal reflux disease (GERD), including erosive esophagitis and symptomatic GERD; long term treatment of pathologic hypersecretor y conditions(e.g. , ZollingerEllison syndrome, multiple endocrine adenomas, systemic multiple endocrine adenomas, systemic mastocytosis); to maintain

SIDE EFFECTS Hypersensitivit y. Lactation and children. Combination therapy with clarithomycin should not be used in patients with hepatic impairment.

ADVERSE REACTION Angina, tachycardia, bradycardia; palpitation, headache, dizziness, rash, diarrhea, abdominal pain, acid regurgitation, nausea, vomiting, constipation, flatulence, cough, upper respiratory infection, asthenia, back pain.

NURSING CONSIDERATI ON 1. Take as directed, before eating. 2. Do not crush or chew capsules. 3. Delayed release capsule may be opened and contents added to apple sauce. 4. Caution patient to avoid alcohol, salicylate s, ibuprofen : may cause GI irritation. 5. Patient may experienc e anorexia;

healing of erosive esophagitis; in combination with clarithromycin to eradicate H. pylori, use clarythromyci n and amoxicillin in combination with omeprazole in patients with a 1-yr history of duodenal ulcers or active duodenal ulcers to eradicate H. pylori; short term treatment of active benign gastric ulcer.

small frequent meals may help to maintain adequate nutrition. 6. Report severe headache , or changes in respirator y status. Inform physician if patient or intends to become pregnant. Breastfee ding is not recomme nded.

GENERIC Clopidogrel

BRAND NAME Plavix

DOSAGE USED FOR PATIENT 1 tab od

INDICATION Reduction of atherosclerotic events (myocardial infarction, stroke and vascular death) in patients w/ atherosclerotic documented by recent stroke, myocardial infarction or established peripheral arterial disease. Treatment of patients suffering from non-ST segment elevation acute coronary

SIDE EFFECTS Hypersensitivit y. Severe liver impairment. Active pathological bleeding i.e. peptic ulcer and intracranial hemorrhage. Pregnancy and lactation.

ADVERSE REACTION GI bleeding, purpura, bruising, hematoma, epistaxis, hematuria, eye bleeding (mainly conjuctival), intracranial bleeding. GI disturbances, diarrhea. Rash, pruritus.

NURSING CONSIDERATI ON 1. Advise patient that blood work will be necessar y during treatmen t. 2. Instruct patient to take drug as directed by the physician . 3. Advice patient that drug may impair ability to drive or operate machiner

syndrome (unstable angina or nonQ wave MI) in combination w/ aspirin (ASA)

y, thus avoid tasks that require mental alertness . 4. Advice patient to report any anusual bleeding to physician , tat may take longer than usual to stop bleeding. 5. Caution patient to report diarrhea, skin rashes, subcutan eous bleeding, chills, fever, sore throat

6. Advice patient to tell physician and dentist that clopidogr el is used before any schedule d surgery or dental procedur e.

GENERIC Losartan

BRAND NAME Cozzar

DOSAGE USED FOR PATIENT

INDICATION Treatment of hypertension; in heart failure and myocardial infarction, it may be used alone or in combination w/ another antihypertensi

SIDE EFFECTS Pregnany (Category D). Breastfeeding, renal artery stenosis, hyperkalemia. Hypersensitivit y. Anuria. Patients who are hypersensitive

ADVERSE REACTION Diziness and dose-related orthostatic hypotension. Impaired renal function and rarely, rash, angioedema, and raised alanine aminotransfer

NURSING CONSIDERATI ON 1. Advice patient to comply with dosage schedule, even if feeling better. 2. Tell patient to

ve agents. Renal protection in TYPE 2 diabetic patients w/ proteinuria. Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients w/ left ventricular hypertrophy.

to other sulfonamidederived drugs.

ase. Hyperkalemia and myalgia, facial edema, fever, angina pectoris, 2nd degree AV block, arrhythmias, diarrhea, dry mouth, anemia, gout, muscle cramps, arthritis, anxiety disorder. Rarely, raised liver enzymes values. Taste disturbances progressing to complete taste loss. Severe migraine. Over dosage: hypotension and tachycardia.

avoid sodium substitut e because they may contain potassiu m which can cause hyperkal emia in patients taking the drug. 3. Inform patient that drug may cause dizziness, fainting or lightheadedn ess. Caution patient to rise slowly to sitting or standing position to minimize orthostati

c hypotensi on. Advise patient that excessive perspirati on, vomiting and diarrhea may lead to dehydrati on and fall in blood pressure. 4. Instruct patient to report drug induced adverse effects. 5. Advice patient to use contrace ption and to report suspecte d pregnanc y during

therapy. 6. Teach patient to avoid sunlight or wear sunscree n because photosen sitivity may occur.

GENERIC citicoline

BRAND NAME Cytidine

DOSAGE USED FOR PATIENT

INDICATION CVA in acute

SIDE EFFECTS Hypertonia of

ADVERSE REACTION Shock,

NURSING CONSIDERATI ON 1. Teach

diposphate choline,starton yl, brainact, cholinerv, Nicholin,soma zine

and recovery phase. Symptoms and signs of cerebral insufficiency i.e., dizziness, headache, poor concentration, memory loss, disorientation, etc. recent cranial trauma and their sequelae. Parkinson disease.

the parasympathe thic nervous system. Meclofenoxate (clophenoxate)

hypersensitivit y, hypotension, insomnia, excitement. Stimulates parasympathe tic action and fleeting and discreet hypotension effect.

patient to gain benefits and not to miss any dose. 2. Instruct patient to take only the prescribe d medicine s. 3. Advice patient to consult the physician if any problem occurs during medicati on. 4. Caution in pregnanc y and lactation.